Диссертация (1154715), страница 21
Текст из файла (страница 21)
5-34.58.Bager, P. Mode of delivery and risk of allergic rhinitis and asthma / P. Bager, M.Melbye, K. Rostgaard, C.S. Benn, T. Westergaard. // J Allergy Clin Immunol — 2003.— Vol. 111 (1). — P. 51-56.59.140Banerjee, R.R. Regulation of fasted blood glucose by resistin / R.R. Banerjee,S.M. Rangwala, J.S.
Shapiro, A.S. Rich, B. Rhoades, Y. Qi, J. Wang, M.W. Rajala, A.Pocai, P.E. Scherer, C.M. Steppan, R.S. Ahima, S. Obici, L. Rossetti, M.A. Lazar //Science. — Vol. 303 (5661). — P. 1195-1198.60.Barnes, P.J. Nitric oxide and asthmatic inflammation / P.J. Barnes, F.Y. Liew //Immunol Today. — 1995. — Vol. 16 (3). — P. 128-130.61.Bassuny, W.M. Association study between interleukin-12 receptor beta 1/beta 2genes and type 1 diabetes or asthma in the Japanese population / W.M.
Bassuny, K.Ihara, J. Kimura, S. Ichikawa, R. Kuromaru, K. Miyako, K. Kusuhara, Y. Sasaki, H.Kohno, N. Matsuura, S. Nishima, T. Hara. // Immunogenetics. — 2003. — Vol. 55 (3).— P. 189-192.62.Battaglia, M. The streetlight effect in type 1 diabetes / M. Battaglia, M.A.Atkinson // Diabetes. — 2015. — Vol. 64 (4). — P. 1081-1090.63.Becklake, M.R. Gender differences in airway behaviour over the human life span/ M.R. Becklake, F. Kauffmann // Thorax. — 1999.
— Vol. 54 (12). — P. 1119-1138.64.Billington, C.K. Novel cAMP signalling paradigms: therapeutic implications forairway disease / C.K. Billington, I.P. Hall // Br J Pharmacol. — 2012. — Vol. 166 (2).— P. 401-410.65.Bjornson, C.L. Gender differences in asthma in childhood and adolescence / C.L.Bjornson, I.
Mitchell // J Gend Specif Med. — 2000. — Vol. 3 (8). — P. 57-61.66.Black, M.H. Prevalence of asthma and its association with glycemic controlamong youth with diabetes / M.H. Black, A. Anderson, R.A. Bell, D. Dabelea, C.Pihoker, S. Saydah, M. Seid, D.A. Standiford, B. Waitzfelder, S.M. Marcovina, J.M.Lawrence // Pediatrics. — 2011. — Vol. 128 (4). — P. 839-847.67.Blom, L. The Swedish Childhood Diabetes study: vaccinations and infections asrisk determinants for diabetes in childhood / L. Blom, L.
Nyström, G. Dahlquist //Diabetologia. — 1991. — Vol. 34 (3). — P. 176-181.68.Bousquet, J. Allergic rhinitis and its impact on asthma (ARIA) 2008 update / J.Bousquet, N. Khaltaev, A. Cruz, J. Denburg et al. // Allergy. — 2008. — Vol. 63 (86).— P. 8-160.69.141Brightling, C.E. Efficacy and safety of tralokinumab in patients with severeuncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial /C.E. Brightling, P.
Chanez, R. Leigh, P.M. O’Byrne, S. Korn, D. She, R. May, K.Striecher, K. Ranade, E. Piper // Lancet Respir Med — 2015. — Vol. 3 (9). — P. 692701.70.Bronnimann, S.A prospective study of the natural history of asthma. Remissionand relapse rates / S. Bronnimann, B. Burrows // Chest. — 1986.
— Vol. 90 (4). — P.480-484.71.Caffarelli, C. Coexistence of IgE-mediated allergy and type 1 diabetes inchildhood / C. Caffarelli, G. Cavagni, R. Pierdomenico, G. Chiari, A. Spattini, M.Vanelli // Int Arch Allergy Immunol. — 2004. — Vol. 134 (4). — P. 288-294.72.Cakir, M. Prevalence of atopy in children with type 1 diabetes mellitus, hepatitisB virus carriers, and healthy children: role of T helper 1 (Th1)-type immune response /M.
Cakir, S. Akcay, T. Karakas, Y. Gedik, A. Okten, F. Orhan. // Allergy Asthma Proc.— 2008. — Vol. 29 (2). — P. 166-170.73.Cardwell, C.R. A meta-analysis of the association between childhood type 1diabetes and atopic disease / C.R. Cardwell, M.D. Shields, D.J. Carson, C.C. Patterson.Diabetes Care — 2003. — Vol. 26 (9). — P. 2568-2574.74.Cardwell, C.R. Atopy, home environment and the risk of childhood-onset type 1diabetes: a population-based case-control study / C.R.
Cardwell, D.J. Carson, J. Yarnell,M.D. Shields, C.C. Patterson // Pediatr Diabetes. — 2008. — Vol. 9 (3). — P. 191-196.75.Cardwell, C.R. Breast-feeding and childhood-onset type 1 diabetes / C.R.Cardwell, L.C. Stene, J. Ludvigsson, J. Rosenbauer et al. // Diabetes Care. — 2012. —Vol. 35 (11). — P. 2215-2225.76.Cardwell, C.R. Caesarean section is associated with an increased risk ofchildhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies / C.R.Cardwell, L.C. Stene, G. Joner, O. Cinek et al.
// Diabetologia. — 2008. — Vol. 51 (5).— P. 726-735.77.Carvalho, V.F. Mast cell changes in experimental diabetes: focus on attenuationof allergic events / V.F. Carvalho, E.O. Barreto, R.S. Cordeiro, V. Lagente, M.A.142Martins, P.M. e Silva // Mem Inst Oswaldo Cruz. — 2005.
— Vol. 100 (1). — P. 121125.78.Castro, M. Reslizumab foe inadequately controlled asthma with elevated bloodeosinophil counts: results from two multicenter, parallel, double-blind, randomized,placebo-controlled, phase 3 trials / M. Castro, J. Zangrilli, M.E. Wechlser, E.D.Bateman, G.G. Brusselle, P. Bardin, K. Murphy, J.F.
Maspero, C. O'Brien, S. Korn //Lancet Respir Med. — 2015. — Vol. 3 (5). — P. 355-366.79.Chang, R.H. Nitric oxide increased interleukin-4 expression in T lymphocytes /R.H. Chang, M.H. Feng, W.H. Liu, Lai M.Z. // Immunology. — 1997. — Vol. 90 (3).— P. 364-369.80.Chuchalin, A.G. Chronic respiratory diseases and risk factors in 12 regions of theRussian Federation / A.G. Chuchalin, N. Khaltaev, N. Аntonov, D.V.
Galkin, L.G.Manakov, P. Antonini, M. Murphy, A.G. Solodovnikov, J. Bousquet, M.H. Pereira, I.V.Demko // International Journal of COPD. — 2014. — Vol. 9. — P. 963-974.81.Condliffe, A.M. Phosphoinositide 3-kinase: a critical signalling event inpulmonary cells / A.M. Condliffe, K.A. Cadwallader, T.R. Walker, R.C. Rintoul, A.S.Cowburn, E.R. Chilvers // Respir Res. — 2000. — Vol. 1 (1). — P. 24-29.82.Crump, C. Risk of asthma in young adults who were born preterm: a Swedishnational cohort study / C.
Crump, M.A. Winkleby, J. Sundquist, K. Sundquist //Pediatrics. — 2011. — Vol. 127 (4). — P. 913-920.83.Davies, H.T. When can odds ratios mislead? / H.T. Davies, I.K. Crombie, M.Tavakoli // BMJ. — 1998. — Vol. 316. — P. 989-991.84.Dawson, K.P. Acute asthma, salbutamol and hyperglycaemia / K.P. Dawson,A.C. Penna, P.
Manglick // Acta Paediatr. — 1995. — Vol. 84 (3). — P. 305-307.85.Decreased prevalence of atopic diseases in children with diabetes / TheEURODIAB Substudy 2 Study Group // J Pediatr. — 2000. — P. 137 (4). — P. 470474.86.Definition, diagnosis, andclassification of diabetesmellitusand itscomplications: report of a WHO consultation. Part 1: diagnosis and classification of143diabetes mellitus [Электронный ресурс].
— Geneva, Switzerland: WHO, 1999. —Режим доступа: http://diabetestype2.ca/books/WHO_NCD_NCS_99.2.pdf87.Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia:report of a WHO/IDF consultation [Электронный ресурс]. — Geneva, Switzerland:WHO,2006.—Режимдоступа:http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf88.De Marco, R. Differences in incidence of reported asthma related to age in menand women. A retrospective analysis of the data of the European Respiratory HealthSurvey / R. de Marco, F. Locatelli, J. Sunyer, P.
Burney // Am J Respir Crit Care Med.— 2000. — Vol. 162 (1). — P. 68-74.89.De Marco, R. Incidence and remission of asthma: a retrospective study on thenatural history of asthma in Italy / R. de Marco, F. Locatelli, I. Cerveri, M. Bugiani, A.Marinoni, G. Giammanco // J Allergy Clin Immunol. — 2002. — Vol. 110 (2). — P.228-235.90.Dekkers, B.G. Insulin-induced laminin expression promotes a hypercontractileairway smooth muscle phenotype / B.G.
Dekkers, D. Schaafsma, T. Tran, J. Zaagsma,H. Meurs // Am J Respir Cell Mol Biol. — 2009. — Vol. 41 (4). — P. 494-504.91.DerSimonian, R. Meta-analysis in clinical trials revisited / R. DerSimonian, N.Laird // Contemp Clin Trials. — 2015. — Vol.
45. — P. 139-145.92.Diana, J. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendriticcells initiates autoimmune diabetes / J. Diana, Y. Simoni, L. Furio, L. Beaudoin, B.Agerberth, F. Barrat, A. Lehuen // Nat. Med. — 2013. — Vol. 19 (1). — P. 65-73.93.Dodge, R.R. The prevalence and incidence of asthma and asthma-like symptomsin a general population sample / R.R.
Dodge, B. Burrows // Am Rev Respir Dis. —1980. — Vol.122 (4). — P. 567-575.94.Douek, I.F. Children with type-1 diabetes and their unaffected siblings havefewer symptoms of asthma / I.F. Douek, N.J. Leech, H.A. Gillmor, P.J. Bingley, E.A.Gale // Lancet. — 1999. — Vol. 353 (9167). — P. 1850.95.144Doukas, J. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115[3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol]asatherapeuticcandidate for asthma and chronic obstructive pulmonary disease / J. Doukas, L.
Eide, K.Stebbins, A. Racanelli-Layton, L. Dellamary, M.Martin, E. Dneprovskaia, G.Noronha, R. Soll, W. Wrasidlo, L.M. Acevedo, D.A. Cheresh // J Pharmacol Exp Ther.— 2009. — Vol. 328 (3). — P. 758-765.96.Dünser, M.W. Sympathetic overstimulation during critical illness: adverse effectsof adrenergic stress / M.W.
Dünser, W.R. Hasibeder // J Intensive Care Med. — 2009.— Vol. 24 (5). — P. 293-316.97.Duran, C. Frequency of atopy and allergic disorders among adults with Type 1diabetes mellitus in the southern Marmara region of Turkey / C. Duran, D. Ediger, C.Ersoy, N.F. Coskun, H. Selimoglu, I.
Ercan, S. Kiyici, M. Guclu, D.A. Saglam, E.Erturk, E. Tuncel, S. Imamoglu // J. Endocrinol. Invest. — 2008. — Vol. 31 (3). — P.211-215.98.Dutu, A.G. Allergic diseases in type 1 diabetic patients: a brief review / A.G.Dutu, S. Albu // Romanian Journal of Infectious Diseases. — 2015. — Vol. 18 (2-3). —P. 65-71.99.Dweik, R.A. An official ATS clinical practice guideline: Interpretation of exhalednitric oxide levels (FENO) for clinical applications / R.A. Dweik, P.B. Boggs, S.C.Erzurum, C.G. Irvin, M.W. Leigh, J.O. Lundberg, A.C. Olin, A.L. Plummer, D.R.Taylor // Am. J. Respir.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
